Inflammatory arthritis: biologics may decrease cardiovascular events

Australian study finds association

Patients taking biologics for inflammatory arthritis may have a reduced risk of cardiovascular events (CVE) compared with those who are biologic-naive, but the effect disappears after ceasing the agents, an Australian study suggests.

Analysis of data from 4140 patients in the Australian Rheumatology Association Database (ARAD) showed that those taking anti-TNF biologics had 15% lower risk of a CVE than those who had never taken any biologic drug.

The small number of patients (128) who had taken other types of biologic appeared to be at similar reduced